Candidiasis: Clinical Trials

71 trials for Candidiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

48 completed, 9 unknown, 7 recruiting, 3 not yet recruiting. 71 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable71Completed 48, Unknown 9, Recruiting 7, Not yet recruiting 3, Terminated 3, Active not recruiting 1

Follow Candidiasis: new trials by email Literature Review of Candidiasis trials Research Report on Candidiasis

Trials (filtered) newest first · largest first

All 71 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Photobiomodulation for Vaginal Dysfunctions: Home-Based vs Outpatient Treatment
Blue LED Photobiomodulation - Genitourinary Syndrome of Menopause (GSM), Bacterial Vaginosis
Not applicableNot yet recruitingPatricia Lordelo1502026-07-302026-07-13
Improving Prescribing Quality for Oral Mucosal Disorders Using a Pharmacist-Led Model
Pharmacist-Led Prescribing Optimization and Patient Counselling - Oral Lichen Planus, Recurrent Aphthous Stomatitis
Not applicableNot yet recruitingUniversity of Fujairah3362026-07-012026-07-22
Evaluation of the Efficacy of a Probiotic Product as an Adjuvant Treatment for Vulvovaginal Candidiasis
Bioithas WOMAN® - Vulvovaginal Candidiasis (VVC)
Not applicableRecruitingBioithas SL602026-05-252026-05-22
The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study
Vaginal lactoferrin, Usual care - Bacterial Vaginosis, Candida Vaginal
Not applicableRecruitingGuy's and St Thomas' NHS Foundation Trust1142026-04-162026-05-29
An Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Vulvovaginal Candidiasis Compared With an Untreated Control Group
pHyph - Vulvovaginal Candidiasis (VVC)
Not applicableActive not recruitingGedea Biotech AB482026-03-032026-05-14
Multi-Gyn FemiTotal for the Treatment and Prevention of Vulvovaginal Candidiasis Symptoms and Bacterial Vaginosis
Multi-Gyn FemiTotal - Bacterial Vaginosis, Vaginal Candidiasis
Not applicableRecruitingKaro Pharma AB802025-10-222026-10-02
Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)
vaginal cooling device - Vulvovaginal Candidiasis (VVC), Yeast Vaginitis
Not applicableRecruitingCoologics, Inc552025-05-222026-01-30
Efficacy of the Vacucis Candida® Autovaccine
Vacucis autovaccine, Placebo - Oral Candidiasis, Oral Candidiasis Recurrent
Not applicableNot yet recruitingUniversity of Santiago de Compostela462025-04-302024-10-17
Effect of a Multi-strain Probiotic on Recurrent Vulvovaginal Candidiasis
Probiotic, Placebo - Vulvovaginal Candidiasis
Not applicableRecruitingThe Archer-Daniels-Midland Company1262024-10-152024-11-07
Point of Care Diagnosis of Vaginal Infections
Xpert® Xpress MVP test, Usual Care - Vaginitis, Bacterial Vaginosis
Not applicableCompletedSharon L Hillier3512024-06-162026-04-08
Clinical Study to Evaluate the Efficacy of an Anti-Fungal Supplement
CanXida Remove (Formula RMV), Placebo - Candida Systemic, Candida Albicans Infection
Not applicableCompletedCanXida602023-11-302024-08-22
Comparison of Uncomplicated Candidemia Therapy Duration in Children and Adults
therapy duration - Invasive Candidiasis
Not applicableRecruitingArkansas Children's Hospital Research Institute4202023-09-082026-10-30
Zinc-containing Vaginal Gel and Oral Fluconazole for Vulvovaginal Candidiasis.
JUVIA zinc containing vaginal gel treatment, Fluconazole 150Mg Tab - Vulvovaginal Candidiasis, Vaginal Yeast Infections
Not applicableCompletedFEMPHARMA Kft.642023-06-102026-09-02
Lacticaseibacillus Rhamnosus CA15 (DSM 33960) Strain as a New Driver in Restoring the Normal Vaginal Microbiota
Lacticaseibacillus rhamnosus CA15 (DSM 33960) probiotic strain, placebo - Bacterial Vaginosis, Candidosis Vaginal
Not applicableCompletedAgnese Maria Chiara Rapisarda2002023-04-102025-07-28
Blue Light Emitting Diode Therapy on Vulvovaginal Candidiasis
Blue Light Emitting Diode Therapy, Azole Antifungal - Recurrent Vulvovaginal Candidiasis
Not applicableCompletedCairo University602023-04-012024-05-02
Clinical Performance of the Gedea Pessary in Adult Women With Vulvovaginal Candidiasis
pHyph generation II - Vulvovaginal Candidiasis
Not applicableCompletedGedea Biotech AB262023-03-162025-10-06
Multi-Gyn FloraFem Study for Treatment of Vulvo Vaginal Candidiasis Symptoms
Multi-Gyn FloraFem - Vulvovaginal Candidiasis
Not applicableCompletedKaro Pharma AB402023-02-202023-06-01
Genital Hygiene Training Provided to Turkish Women
Genital hygiene training - Genital Hygiene, Genital Hygiene Behaviors
Not applicableCompletedInonu University1142022-11-222023-08-21
Oral Lactobacillus Crispatus Lc-G22 as Adjunctive Therapy for Vulvovaginal Candidiasis
Lactobacillus crispatus Lc-G22, Placebo - Vulvovaginal Candidiasis
Not applicableCompletedBioGrowing Co., Ltd1002022-07-012026-07-27
Candida PCR Diagnosis Strategy in Patients From Intensive Care Units
Diagnosis strategy based on C. glabrata / krusei PCR - Candida
Not applicableCompletedUniversity Hospital, Toulouse482022-05-192026-08-11

Showing 20 of 71. Sign in to see all of them.

Narrower conditions

Candidiasis, Vulvovaginal (30)  ·  Candidiasis, Oral (20)  ·  HIV Infections (15)  ·  Acquired Immunodeficiency Syndrome (11)  ·  AIDS-Related Complex (8)  ·  AIDS-Related Opportunistic Infections (8)  ·  Candidiasis, Invasive (7)  ·  Torulopsis (6)  ·  Vaginosis, Bacterial (6)  ·  Candidemia (4)  ·  Stomatitis, Denture (4)  ·  Vaginitis (4)  ·  Mouth, Edentulous (3)  ·  Vaginal Diseases (3)

Broader conditions

Bacterial Infections and Mycoses (71)  ·  Infections (70)  ·  Mycoses (69)  ·  Urogenital Diseases (48)  ·  Genital Diseases (47)  ·  Female Urogenital Diseases and Pregnancy Complications (33)  ·  Female Urogenital Diseases (32)  ·  Genital Diseases, Female (30)  ·  Vulvar Diseases (30)  ·  Vulvitis (30)  ·  Vaginal Diseases (29)  ·  Vulvovaginitis (28)  ·  Vaginitis (27)  ·  Mouth Diseases (23)

Interventions

Fluconazole (10)  ·  Itraconazole (4)  ·  Nystatin (4)  ·  Clotrimazole (2)  ·  Probiotics (2)  ·  6-phospho-beta-galactosidase (1)  ·  Amphotericin B (1)  ·  Anidulafungin (1)  ·  Caspofungin (1)  ·  Dapsone (1)  ·  Dentifrices (1)  ·  Duration of Therapy (1)  ·  Iron, Dietary (1)  ·  Ketoconazole (1)  ·  Lacteol (1)

Sponsors

Bristol-Myers Squibb (4)  ·  Pfizer (4)  ·  Gedea Biotech AB (3)  ·  Cairo University (2)  ·  Janssen, LP (2)  ·  Karo Pharma AB (2)  ·  Padagis LLC (2)  ·  Raphael Freitas de Souza (2)  ·  University of Copenhagen (2)  ·  Agnese Maria Chiara Rapisarda (1)  ·  Arkansas Children's Hospital Research Institute (1)  ·  BioGrowing Co., Ltd (1)  ·  Biocodex (1)  ·  Bioithas SL (1)  ·  Biosearch S.A. (1)

Countries

United States (24)  ·  Brazil (6)  ·  France (6)  ·  Spain (4)  ·  Sweden (4)  ·  Canada (3)  ·  Austria (2)  ·  China (2)  ·  Italy (2)  ·  Mauritius (2)  ·  Turkey (Türkiye) (2)  ·  Argentina (1)  ·  Australia (1)  ·  Belgium (1)  ·  Denmark (1)

Top investigators

Adrian Gaspar, MD (1)  ·  Aino Fianu Jonasson, MD, PhD (1)  ·  Ana Beatriz S Lopes, Graduated (1)  ·  Anahita Rouze, MD (1)  ·  Armin Witt, MD (1)  ·  Asmaa Swidan, MBBCh (1)  ·  Barbara D Alexander, MD (1)  ·  Bence Kozma, MD PhD (1)  ·  Brian Fisher, DO (1)  ·  Fadlina Adnan, MD (1)  ·  Hatem Abu Hashim, MD. FRCOG. PhD (1)  ·  Heather Tharpe, Rn, BSN, OCN (1)  ·  Helena FO Paranhos, DDS, PhD (1)

Results publications

PMID 17719934, PMID 22879929, PMID 26202995, PMID 28232977, PMID 28476133, PMID 28584537, PMID 30233654, PMID 30406341, PMID 35005777, PMID 35628743, PMID 36395084, PMID 38350486, PMID 41471856, PMID 42117698, PMID 42464124

NIH funding

2009 (1), 2017 (1), 2018 (1), R01AI170385 (1)